Xueshan Sun

Dr. Xueshan Sun

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2022 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
LDLing Bin Du
Ling Bin Du
JXJunfang Xu
Junfang Xu
YGYuxuan Gu
Yuxuan Gu
XSXueshan Sun
Xueshan Sun
DHDong Hengjin
Dong Hengjin
CCChanggui Chen
Changgui Chen
Background: Esophageal cancer (EC) is the sixth leading cause of tumor-related deaths worldwide. Estimates of the EC burden are necessary and could offer evidence-based suggestions for local cancer control. Objective: The aim of this study was to predict the disease burden of EC in China through the estimation of disability-adjusted life years (DALYs) and direct medical expenditure by sex from 2013 to 2030. Methods: A dynamic cohort Markov model was developed to simulate EC prevalence, DALYs, and direct medical expenditure by sex. Input data were collected from the China Statistical Yearbooks, Statistical Report of China Children’s Development, World Population Prospects 2019, and published papers. The JoinPoint Regression Program was used to calculate the average annual percentage change (AAPC) of DALY rates, whereas the average annual growth rate (AAGR) was applied to analyze the changing direct medical expenditure trend over time. Results: From 2013 to 2030, the predicted EC prevalence is projected to increase from 61.0 to 64.5 per 100,000 people, with annual EC cases increasing by 11.5% (from 835,600 to 931,800). The DALYs will increase by 21.3% (from 30,034,000 to 36,444,000), and the years of life lost (YLL) will account for over 90% of the DALYs. The DALY rates per 100,000 people will increase from 219.2 to 252.3; however, there was a difference between sexes, with an increase from 302.9 to 384.3 in males and a decline from 131.2 to 115.9 in females. The AAPC was 0.8% (95% CI 0.8% to 0.9%), 1.4% (95% CI 1.3% to 1.5%), and –0.7% (95% CI –0.8% to –0.7%) for both sexes, males, and females, respectively. The direct medical expenditure will increase by 128.7% (from US $33.4 to US $76.4 billion), with an AAGR of 5.0%. The direct medical expenditure is 2-3 times higher in males than in females. Conclusions: EC still causes severe disease and economic burdens. YLL are responsible for the majority of DALYs, which highlights an urgent need to establish a beneficial policy to reduce the EC burden.

29 August 2024 in BMJ Open
Verified
Journal Article
Open access
PDF file
WYWenqianzi Yang
Wenqianzi Yang
XZXuemei Zhen
Xuemei Zhen
XSXueshan Sun
Xueshan Sun
XZXuepei Zhang
Xuepei Zhang
DYDanhong Yang
Danhong Yang
DHDong Hengjin
Dong Hengjin
Objectives: This analysis aims to better reflect the value of new antibiotic treatment strategies, thereby informing clinical antibiotic use, antimicrobial reimbursement and/or hospital formulary decision-making in China. Design: We adapted a published and validated dynamic disease transmission and cost-effectiveness model to evaluate the clinical and economic outcomes of introducing a new antibiotic, ceftazidime/avibactam (CAZ-AVI) for treating resistant infections in Zhejiang province, China. Outcomes were assessed over a 10-year infectious period and an annual discount rate of 5%. Costs were extracted from the hospital’s Health Information System (HIS) and obtained after data cleaning, aggregation and discounting. Setting: The Chinese healthcare system perspective. Participants: 10 905 patients in a Chinese tier-3 hospital from 2018 to 2021 with any of the three common infections (complicated intra-abdominal infection (cIAI), hospital-acquired/ventilator-associated pneumonia (HAP/VAP) and infections with limited treatment options (LTO)) caused by three common resistant pathogens ( Escherichia coli, Klebsiella spp. and Pseudomonas aeruginosa ). Interventions: (1) Current treatment strategy (piperacillin-tazobactam (pip/taz) and meropenem); (2) CAZ-AVI at the third line; (3) CAZ-AVI at the second line; (4) CAZ-AVI at the first line; (5) CAZ/AVI first line, two lines diversified (i.e., equal pip/taz and CAZ-AVI at the first line; meropenem at the last line) and (6) CAZ/AVI first line, all-lines diversified. Primary outcome measures: Quality-adjusted life years (QALYs) lost, hospitalisation costs and incremental net monetary benefit (INMB) were used to assess cost-effectiveness. Results: Over 10 years, the introduction of CAZ-AVI to the current treatment strategy led to lower hospitalisation costs and more QALYs across all five treatment strategies, with between 68 284 and 78 571 QALYs gained whilst saving up to US$236.37 for each additional QALY gained. The INMB of introducing CAZ-AVI is estimated up to US$3 550 811 878. Conclusions: Introducing CAZ-AVI had a positive impact on clinical and economic outcomes for treating antimicrobial resistance, and diversifying the antibiotics use early in the treatment might yield the best benefits.

8 February 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
XSXueshan Sun
Xueshan Sun
ZZZhongliang Zhou
Zhongliang Zhou
WWWenhua Wang
Wenhua Wang
Background/Objectives: Patient safety is fundamental to primary healthcare, and medical errors impose a considerable burden on patients globally. However, the impact of medical errors on primary healthcare physicians remains understudied, especially in developing countries. This study aimed to examine the associations between self-reported medical errors and physicians’ performance and confidence in Chinese primary care practice. Methods: A cross-sectional survey was conducted from November 2021 to May 2022 with 224 primary care physicians from 38 community health centers (CHCs) across four large cities in China. The quality of clinical and preventative care, and confidence in managing commonly occurring diseases, multimorbidity, and common mental health disorders served as indicators of performance and confidence, respectively. Hierarchical linear regression and linear regression with cluster-robust standard errors were employed. Results: Clinical care quality (β = −0.159, SE = 0.075, p < 0.05), preventive care quality (β = −0.165, SE = 0.068, p < 0.05), confidence in managing multimorbidity (β = −0.175, SE = 0.074, p < 0.05), and confidence in managing common mental health disorders (β = −0.189, SE = 0.076, p < 0.05) were negatively associated with self-reported medical errors, with scores of 4.08 (SD 0.95), 3.59 (SD 0.87), 3.63 (SD 1.04), and 3.10 (SD 1.21) out of 5 (where 5 represents the best possible score), respectively. The association between self-reported medical errors and confidence in managing commonly occurring diseases (β = −0.063, SE = 0.075, p > 0.05) was not statistically significant, with a score of 3.81 (SD 1.00) out of 5 (where 5 represents the best possible score). Conclusions: This study offers new insight into the associations between self-reported medical errors and primary healthcare physicians’ performance and confidence. It is crucial for CHCs to be aware of the impact of self-reported medical errors on physicians’ performance in delivering clinic and preventative care, and confidence in managing multimorbidity and common mental health disorders. Strategies such as strengthening organizational support should be developed to maintain performance and rebuild confidence in delivering care for physicians who were involved in medical errors.

27 August 2021 in JMIR Preprints
Verified
Preprint
Open access
LDLing Bin Du
Ling Bin Du
JXJunfang Xu
Junfang Xu
YGYuxuan Gu
Yuxuan Gu
XSXueshan Sun
Xueshan Sun
DHDong Hengjin
Dong Hengjin
CCChanggui Chen
Changgui Chen
BACKGROUND Esophageal cancer (EC) is the sixth leading cause of tumor-related deaths worldwide. Estimates of the EC burden are necessary and could offer evidence-based suggestions for local cancer control. OBJECTIVE The aim of this study was to predict the disease burden of EC in China through the estimation of disability-adjusted life years (DALYs) and direct medical expenditure by sex from 2013 to 2030. METHODS A dynamic cohort Markov model was developed to simulate EC prevalence, DALYs, and direct medical expenditure by sex. Input data were collected from the China Statistical Yearbooks, Statistical Report of China Children’s Development, World Population Prospects 2019, and published papers. The JoinPoint Regression Program was used to calculate the average annual percentage change (AAPC) of DALY rates, whereas the average annual growth rate (AAGR) was applied to analyze the changing direct medical expenditure trend over time. RESULTS From 2013 to 2030, the predicted EC prevalence is projected to increase from 61.0 to 64.5 per 100,000 people, with annual EC cases increasing by 11.5% (from 835,600 to 931,800). The DALYs will increase by 21.3% (from 30,034,000 to 36,444,000), and the years of life lost (YLL) will account for over 90% of the DALYs. The DALY rates per 100,000 people will increase from 219.2 to 252.3; however, there was a difference between sexes, with an increase from 302.9 to 384.3 in males and a decline from 131.2 to 115.9 in females. The AAPC was 0.8% (95% CI 0.8% to 0.9%), 1.4% (95% CI 1.3% to 1.5%), and –0.7% (95% CI –0.8% to –0.7%) for both sexes, males, and females, respectively. The direct medical expenditure will increase by 128.7% (from US $33.4 to US $76.4 billion), with an AAGR of 5.0%. The direct medical expenditure is 2-3 times higher in males than in females. CONCLUSIONS EC still causes severe disease and economic burdens. YLL are responsible for the majority of DALYs, which highlights an urgent need to establish a beneficial policy to reduce the EC burden.

14 August 2026 in Humanities and Social Sciences Communications
Verified
Journal Article
Open access
PDF file
JLJiao Lu
Jiao Lu
DSDanyi Sun
Danyi Sun
HZHeng Zhao
Heng Zhao
JBJie Bai
Jie Bai
DWDan Wang
Dan Wang
XSXueshan Sun
Xueshan Sun
With the rapid advancement of digital transformation, e-health services have emerged as an effective means to enhance healthcare equity. However, the development of e-health services in China still faces numerous challenges. To promote its further advancement, understanding the characteristics of public attention to e-health services is crucial. This study aims to investigate the spatiotemporal variation characteristics and supply-demand determinants of public attention to e-health services in China, thereby assessing the effectiveness of China’s e-health service initiatives and formulating targeted policies to facilitate its sustainable development. By collecting data on public attention to e-health services across 31 provinces in China from 2014 to 2021, using the Dagum Gini coefficient, kernel density estimation, Markov chain, and spatial Durbin model, the public attention to e-health services across different regions was measured. The results indicate that: (1) Significant spatial disparities in public attention to e-health services exist across China, although the overall disparity is decreasing, with inter-regional differences being the primary contributor; (2) Public attention to e-health services in China exhibits persistent spatial imbalance and a gradient effect, with varying degrees of imbalance observed both between regions and among provinces within each region; (3) Regarding dynamic evolution patterns, the state of public attention to e-health services to be stable in the short term; (4) In terms of influencing factors, supply-side and demand-side factors exert distinct impacts on public attention to e-health services, and due to differing development priorities concerning economic growth and livelihood improvement, these factors exhibit heterogeneous spillover effects across the eastern, central, and western regions. Therefore, this study recommends that regional governments strengthen foundational infrastructure, optimize the e-health development ecosystem, and implement differentiated construction strategies to narrow the gap in healthcare resource allocation and advance regional health equity in e-health services.